Our past and present projects

Develop Sanofi Genzyme business in Central Asia and Caucasus countries with launching new rare portfolio products in lysosomal disorders diseases

Provide expanded access for new exon-skipping therapies for all eligible Duchenne Muscular diseases patients in Kazakhstan and Central Asia

Set up diagnostic and patient support programs for Duchenne patients in Uzbekistan and Azerbaijan countries

Set up diagnostic and patient support programs for Urea cycle disorders (UCD) patients in Kazakhstan and provide expanded access to treatment

We provide testing solutions In Vitro Diagnostics for Healthcare Solutions

We deliver innovative therapies and solutions from Chiesi Rare Diseases for individuals with rare diseases, their caregivers and healthcare professionals in Kazakhstan

Reviews
Michel Van Harten
CEO MyTomorrows

Collaboration with Farrukh and his company Pharm&Access allowed us to service physicians and their Duchenne Muscular Disease patients with unmet medical needs. We hope that our continued joined efforts will allow such patients to have access to all possible treatment options.

Charles Gerrits
Vice President of Sarepta Therapeutics

We have been partnering with Farrukh and his company Pharm&Access almost 3 years with helping hundreds of patients with Duchenne disease (DMD) to improve their quality of life in Central Asia and Caucasus countries. During these 3 years we build our partnership and helped most patients with DMD. We expect helping more patients access for a better life in future.